Diagnosis & Criteria - Defining the Dread
- Hallmark: Recurrent, unexpected panic attacks.
- Followed by ≥1 month of one or both:
- Persistent concern about future attacks or their consequences (e.g., "going crazy").
- Significant maladaptive behavior change related to attacks (e.g., avoiding exercise).
- Panic Attack: Abrupt fear surge peaking within minutes with ≥4 of 13 official symptoms.
- 📌 Common symptoms: Palpitations, sweating, trembling, shortness of breath, chest pain, dizziness, paresthesias, derealization, fear of dying or losing control.
⭐ Key differentiator: The panic attacks are uncued ("out of the blue"). If attacks are consistently triggered by a specific situation, consider another diagnosis like a specific phobia or social anxiety disorder.
Pathophysiology - Brain on Fire
- Neurotransmitter Dysregulation: Imbalance in key systems.
- Norepinephrine (NE): ↑ activity, especially from the locus coeruleus (the brain's "panic button").
- Serotonin (5-HT): ↓ levels, leading to poor mood and anxiety regulation.
- GABA: ↓ inhibitory function, causing unchecked neuronal firing.
- Fear Circuitry: Hyperactive amygdala (fear center) with poor top-down control from the prefrontal cortex (PFC).

⭐ Patients with panic disorder often exhibit hypersensitivity to carbon dioxide ($CO_2$) inhalation, which can trigger panic attacks in a laboratory setting.
Clinical Features & Differentials - The Sudden Storm
- Abrupt surge of intense fear peaking within minutes. Requires ≥4 of 13 DSM-5 symptoms:
- Palpitations, sweating, trembling, shortness of breath (SOB).
- Chest pain, dizziness, nausea, paresthesias.
- Derealization/depersonalization, fear of losing control or dying.
- Crucial Differentials (Rule Out First):
- Medical: Myocardial infarction, pulmonary embolism, hyperthyroidism, pheochromocytoma, hypoglycemia.
- Substance-Induced: Caffeine, stimulants (cocaine, amphetamines), alcohol/sedative withdrawal.
⭐ Panic disorder patients often present to the ED fearing a heart attack; an EKG is essential to rule out cardiac ischemia.
Management - Taming the Terror
- Long-Term (First-Line): SSRIs/SNRIs and CBT are cornerstones. SSRIs require 4-6 weeks for full effect. CBT focuses on exposure and cognitive restructuring.
- Acute Management: Benzodiazepines provide rapid relief but should be used short-term (<4 weeks) as a bridge due to dependence risk.
- Treatment Duration: Continue successful pharmacotherapy for at least 6-12 months after remission to prevent relapse.
⭐ Initial SSRI treatment can paradoxically worsen anxiety. Counsel patients on this risk and use a "start low, go slow" titration strategy.
Comorbidities & Prognosis - The Ripple Effect
Error generating content for this concept group: Invalid JSON response
High‑Yield Points - ⚡ Biggest Takeaways
- Recurrent, unexpected panic attacks followed by ≥1 month of persistent worry about future attacks or maladaptive behavior changes.
- Strongly associated with agoraphobia, the fear of situations where escape might be difficult.
- First-line treatment is a combination of SSRIs (e.g., sertraline) and Cognitive Behavioral Therapy (CBT).
- Benzodiazepines are effective for acute management but are not preferred for long-term use due to dependence risk.
- Always rule out underlying medical causes like hyperthyroidism, pheochromocytoma, and cardiac arrhythmias.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app